Peter Abadir

Medicine & Life Sciences

1. Angiotensin Type 1 Receptor 100%
2. Angiotensin Type 2 Receptor 88%
3. Frailty 82%
4. Angiotensins 76%
5. Renin-Angiotensin System 67%
6. Inflammation 53%
7. Angiotensin Receptors 51%
8. Valsartan 51%
9. Angiotensin II 47%
10. Losartan 45%
11. National Institute on Aging (U.S.) 38%
12. Angiotensin Receptor Antagonists 37%
13. Wound Healing 35%
14. Geriatrics 34%
15. Lisinopril 33%
16. Physical Functional Performance 30%
17. Longevity 29%
18. Interleukin-10 26%
19. Bradykinin B2 Receptors 26%
20. Congresses 25%
21. Kidney 25%
22. Angiotensin-Converting Enzyme Inhibitors 25%
23. Oxidative Stress 25%
24. Interleukin-6 24%
25. Wounds and Injuries 23%
26. Kynurenine 23%
27. Mitochondria 22%
28. Cell-Free Nucleic Acids 21%
29. Hand Strength 21%
30. Brain 21%
31. Alzheimer Disease 20%
32. Drosophila melanogaster 20%
33. Skeletal Muscle 19%
34. Angiotensin II Type 1 Receptor Blockers 18%
35. Cognitive Dysfunction 18%
36. Drosophila 17%
37. Mitochondrial DNA 17%
38. enhancer-binding protein AP-3 16%
39. Genotype 14%
40. Dementia 14%
41. Independent Living 14%
42. Metabolomics 14%
43. LCZ 696 14%
44. 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid 13%
45. Mitophagy 13%
46. Cognition 13%
47. Geriatricians 13%
48. Translational Medical Research 13%
49. PD 123319 12%
50. STAT Transcription Factors 12%